Imed Infinity Medical-Limited Partnership

ILA 80.50As of Sun 8 Nov 2026, 12:00 UTC
TASE:IMEDHealthcare
Country Israel
PE (Fwd) •••
TSR 6Y CAGR (24.01%)
Div yield —
ROE (8.18%)
Health Information Services
Beta (5Y) 0.29
PE TTM —
TSR TTM (39.88%)
Mkt cap ILS 6.135M
ROIC (7.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 102
26.12%
46.40%
Hold 1|5|10|12|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.77
0.74
0.81
0.77
14.88%
9.47%
20.11%
6.56%
Revenue$M
0.444
0.448
0.472
0.469
10.41%
9.72%
17.16%
11.87%
Peers (US$1.917M)
Cap (US$)
PE
10.08M
1.046x
Capital
TTM
5Y
10Y
Leveragex
2.878
0.087
0.092
EBIT/Intx
0.585
0.256
0.266
Own earn%
(63.56)
(0.09)
(0.72)
Sh yield%
40.39
30.66
29.13
Owners
Insiders/Inst%
7.27
76.21
Short interest%
1.09
SBC / revenue%
5.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–26
$1 testx
—
Incr. ROIC%
−1